Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Zhang-Auberson
Long-Term Effects of Fingolimod in Multiple Sclerosis: The Randomized FREEDOMS Extension Trial
Neurology
Neurology
Related publications
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMS II Trials
Neurology and Therapy
Neurology
Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis
Patient Related Outcome Measures
Correction To: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMSII Trials
Neurology and Therapy
Neurology
Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment
Neurology
Neurology
Myeloid Cells as Target of Fingolimod Action in Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Long Term Consequences of Arsenical Treatment for Multiple Sclerosis.
BMJ
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
Headache
Neurology
